HDAC9 and plasma cell myeloma: To determine whether canonical histone deacetylase expression levels impact overall survival of patients with multiple myeloma, we analyzed the gene expression profiling dataset of 264 patients with relapsed or refractory multiple myeloma from the APEX study and assessed overall survival in dependence of HDAC expression (4, 28).